Ainscow files to sell 300,000 ASPI shares

Ainscow Robert filed a Form 144 reporting a proposed sale of 300,000 shares of common stock of Independent Trading Group (ITG) Inc., described as acquired as compensation (Restricted Stock Award) on 09/06/2024.

Rhea-AI Filing Summary

Ainscow Robert filed a Form 144 reporting a proposed sale of 300,000 shares of common stock of Independent Trading Group (ITG) Inc., described as acquired as compensation (Restricted Stock Award) on 09/06/2024. The filing also lists securities sold during the past three months: 8,438 shares on 12/08/2025 with an amount shown of 52,340.91.

Insights

Insider Transactions Specialist

Form 144 shows an affiliate intends to sell 300,000 restricted shares acquired 09/06/2024.

The filing lists the security as Common Stock acquired via a Restricted Stock Award and quantifies the proposed sale at 300,000 shares. A prior sale of 8,438 shares on 12/08/2025 with 52,340.91 listed is also reported.

Timing and execution details for the proposed sale are not included in the excerpt; subsequent filings will show actual transactions.

Corporate Governance Analyst

This is a routine affiliate sale notice; it does not by itself change corporate control or strategy.

Form 144 is a regulatory notice required when affiliates intend to sell restricted or control securities. The filing identifies the issuer and the award date but does not state who will receive proceeds or the distribution method.

Impact depends on whether the sales are executed and their size relative to outstanding shares; no such comparative figures are provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ASPI Form 144 filed by Ainscow Robert report?

The Form 144 reports a proposed sale of 300,000 shares of common stock acquired as a Restricted Stock Award on 09/06/2024. It also lists a prior sale of 8,438 shares on 12/08/2025 with 52,340.91 shown.

When were the reported shares acquired according to the ASPI filing?

The filing states the shares were acquired as compensation via a Restricted Stock Award on 09/06/2024. That acquisition date is the only grant date shown in the provided excerpt.

How many shares were sold in the past three months per the ASPI excerpt?

The excerpt lists 8,438 shares sold on 12/08/2025. An associated amount of 52,340.91 is shown alongside that sale entry in the filing excerpt.

Does the Form 144 excerpt specify how the 300,000 shares will be sold?

The excerpt identifies the proposed sale quantity (300,000 shares) and the award date but does not specify the distribution method, broker, or timing for the sale in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 09:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001951275
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ASP Isotopes Inc.
SEC File Number	001-41555
Address of Issuer	2200 Ross Avenue Suite 4575E Dallas TEXAS 75201
Phone	(214) 4328219
Name of Person for Whose Account the Securities are To Be Sold	Ainscow Robert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Independent Trading Group (ITG) Inc. 33 Yonge Street Suite 420 Toronto A6 M5E 1G4	8438	43118.18	110840122	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/06/2024	Acquired as compensation --Restricted Stock Award	Issuer			300000	09/06/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ainscow Robert c/o ASP Isotopes Inc. 2200 Ross Avenue, Suite 4575E Dallas TX 75201	Common Stock	12/08/2025	8438	52340.91

144: Remarks and Signature

Remarks	The sale of shares reported in this Form 144 includes an amount for the purpose of satisfying the Reporting Person's income tax liabilities resulting from the quarterly vesting of a previously granted restricted stock award for 300,000 shares pursuant to an issuer equity incentive plan. The Aggregate Market Value of the shares to be sold is based on the closing market price of $5.11 on March 5, 2026.
Date of Notice	03/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Ainscow
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)